Fundz

Merck KGaA to acquire Rapid Micro Biosystems

RECENTLY ACQUIREDNov 16, 2026

Acquiring Company

Merck KGaA

Acquired Company

RAPID MICRO BIOSYSTEMS

DarmstadtLowellBiotechnologyHealth CareHealthcare

Description

Merck KGaA has signed a definitive agreement to acquire Rapid Micro Biosystems, Inc. This acquisition aims to enhance the Growth Direct platform's reach and accelerate its adoption.

Quick answer

Merck KGaA is acquiring RAPID MICRO BIOSYSTEMS, announced November 16, 2026. Merck KGaA is based in Darmstadt, Hesse, Germany.

How much did Merck KGaA pay for RAPID MICRO BIOSYSTEMS?
The deal value was not disclosed.
What does Merck KGaA do?
Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across life science, healthcare and electronics.
Where are Merck KGaA and RAPID MICRO BIOSYSTEMS based?
Merck KGaA is based in Darmstadt, Hesse, Germany. RAPID MICRO BIOSYSTEMS is based in Lowell, Massachusetts, United States.

Source: Fundz verified event record.

Other recent acquisitions in Healthcare and Biotechnology

Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.

Who to call at Merck KGaA, and when

When Merck KGaA changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Merck KGaA raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Merck KGaA, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Merck KGaA. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Merck KGaA

Location

Darmstadt, Hesse, Germany

About

Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across life science, healthcare and electronics. More than 64,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From providing products and services that accelerate drug development and manufacturing as well as discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2022, Merck KGaA, Darmstadt, Germany, generated sales of € 22.2 billion in 66 countries. The company holds the global rights to the name and trademark “Merck” internationally. The only exceptions are the United States and Canada, where the business sectors of Merck KGaA, Darmstadt, Germany, operate as MilliporeSigma in life science, EMD Serono in healthcare and EMD Electronics in electronics. Since its founding in 1668, scientific exploration and responsible entrepreneurship have been key to the company’s technological and scientific advances. To this day, the founding family remains the majority owner of the publicly listed company.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Merck KGaA makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Merck KGaA's next move

Learn about Strategic plan

Frequently asked

Who acquired RAPID MICRO BIOSYSTEMS?

RAPID MICRO BIOSYSTEMS was acquired by Merck KGaA, based in Darmstadt. The deal was reported on November 16, 2026. Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across life science, healthcare and electronics. Merck KGaA is privately held and operates in Biotechnology.

When did Merck KGaA acquire RAPID MICRO BIOSYSTEMS?

Merck KGaA's acquisition of RAPID MICRO BIOSYSTEMS was reported on November 16, 2026. Merck KGaA has signed a definitive agreement to acquire Rapid Micro Biosystems, Inc. This acquisition aims to enhance the Growth Direct platform's reach and accelerate its adoption. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does RAPID MICRO BIOSYSTEMS do?

RAPID MICRO BIOSYSTEMS, INC. operates within the biotechnology industry, focusing on developing innovative technologies for microbiological testing and quality assurance in the life sciences sector. It is publicly traded (RPID), operating in Healthcare, and is based in Lowell.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.